Kyzatrex Oral Capsules: A Needle-Free Alternative to Testosterone Injections
Injections have long dominated testosterone replacement therapy. For many men, though, the needle is the real barrier. It’s often the single reason they put off treatment altogether. Kyzatrex changes that equation. This FDA-approved oral testosterone undecanoate capsule lets men manage low testosterone without self-injecting or visiting a clinic for a shot. Below, we explain how Kyzatrex works, how it differs from older oral testosterone options, and what to weigh up against injectable TRT.
On this page
- What Is Kyzatrex?
- Why Oral Testosterone Historically Fell Short
- How Kyzatrex Compares to Injectable Testosterone
- Safety Considerations With Kyzatrex
- Is Kyzatrex Right for You?
- A Programme Built Around You
What Is Kyzatrex?
Kyzatrex is a prescription oral capsule containing testosterone undecanoate. The FDA approved it for testosterone replacement therapy in adult men with a diagnosed deficiency or absence of natural testosterone. Patients take it twice daily with a fat-containing meal, which helps the medication absorb properly.
Injectable testosterone requires an intramuscular shot every one to two weeks. Kyzatrex works differently: it fits into a daily routine, much like any other oral medication.
Why Oral Testosterone Historically Fell Short
Oral testosterone has a complicated history. Manufacturers structurally modified older oral androgens, such as methyltestosterone, so the drugs could survive first-pass liver metabolism. That modification came at a cost, however: these medications caused liver strain and, in some cases, liver toxicity. As a result, they largely fell out of favour for testosterone replacement.
Testosterone undecanoate, the active ingredient in Kyzatrex, takes a different path. The intestinal lymphatic system absorbs it directly, so it largely bypasses first-pass liver metabolism and avoids the structural modification that caused problems in older oral androgens. This is one of the key reasons testosterone undecanoate capsules have re-emerged as a viable option, decades after earlier oral products fell out of use.
How Kyzatrex Compares to Injectable Testosterone
Every route of testosterone replacement comes with trade-offs. The right choice depends on the individual. Here are the practical differences worth considering:
- No injections – Kyzatrex removes the need for self-injection or in-clinic administration. For men who are needle-averse, or who simply want a simpler routine, this is often the deciding factor.
- Steadier dosing pattern – because patients take it twice daily, Kyzatrex avoids the pronounced peaks and troughs in testosterone levels that longer-interval injections can cause. With injections, levels peak shortly after the dose, then decline before the next one.
- No injection-site reactions – intramuscular testosterone often causes soreness, bruising, or irritation at the injection site. An oral capsule avoids this entirely.
- Different monitoring needs – injectable testosterone carries a stronger link to increases in red blood cell count (polycythemia), so it requires regular blood monitoring. Oral testosterone undecanoate brings its own monitoring requirement instead, particularly around blood pressure, which your prescriber tracks throughout treatment.
Neither route is universally “safer” than the other. Each carries a distinct risk profile, so your health history, how your body responds, and your prescriber’s clinical judgement should guide the choice.
Safety Considerations With Kyzatrex
Kyzatrex doesn’t suit everyone. Doctors won’t prescribe it to men with known or suspected prostate or breast cancer, and it carries warnings relevant to several other conditions, including:
- Blood pressure increases – hypertension is the most commonly reported side effect. Prescribers monitor blood pressure throughout treatment, especially in men who already have high blood pressure.
- Venous thromboembolism (VTE) – testosterone therapy, including Kyzatrex, has been linked to blood clots such as deep vein thrombosis and pulmonary embolism.
- Sleep apnea – testosterone therapy can worsen obstructive sleep apnea in men who already have the condition.
- Polycythemia – like other testosterone products, Kyzatrex can raise red blood cell count. Because of this, periodic blood testing remains part of ongoing monitoring.
As with any testosterone replacement therapy, bloodwork should confirm a genuine testosterone deficiency before starting Kyzatrex. Treatment then requires ongoing monitoring by a qualified prescriber for as long as it continues.
Is Kyzatrex Right for You?
Many men qualify for TRT but avoid it because of needles, inconvenient injection schedules, or the general hassle of injectable therapy. For these men, Kyzatrex offers a genuinely different path to managing low testosterone. Still, it won’t suit everyone: men with certain cardiovascular risk factors, a history of blood clots, or specific cancer diagnoses may need to consider other options instead. A prescriber who has reviewed your full health history and bloodwork should always make that call with you.
A Programme Built Around You
At PrimeLife, we treat testosterone replacement therapy, including oral options like Kyzatrex, as part of a clinical programme rather than a one-off prescription. Every patient meets with a qualified prescriber, and treatment decisions rest on lab results and a full health assessment, not a generic protocol. Where oral testosterone fits, our clinical team monitors blood pressure and bloodwork throughout treatment, with regular reviews built in.
If needles have held you back from addressing your low testosterone, it’s worth finding out whether an oral option like Kyzatrex fits your situation.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your GP, pharmacist, or qualified healthcare professional before starting, stopping, or changing any treatment. A qualified prescriber must assess individual clinical suitability. PrimeLife only prescribes treatments following a full clinical assessment.

Thomas Harries MPharm IP
Independent Prescribing Pharmacist
Further Reading
White, W. B., et al. (2021). Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men. Journal of Clinical Hypertension.
Miller, J. A., et al. (2023). Oral testosterone therapy: past, present, and future. Sexual Medicine Reviews.
Saad, F., et al. (2020). Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men. International Journal of Obesity.
Hackett, G., et al. (2024). Testosterone replacement therapy: effects on blood pressure in hypogonadal men. World Journal of Men’s Health.
Bhasin, S., et al. (2018). Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism.
